Fibronectin was evaluated as an extracellular matrix protein that supports tumour angiogenesis by promoting endothelial cell adhesion and vessel elongation, rather than as a marker of fibrosis or epithelial–mesenchymal transition [39,40,41]. The gene discussed is FN1; the disease is neoplasm.